Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.
- Tony S. Reed, MD, PhD, MBA, Executive Vice President and Chief Medical Officer of Temple University Health System, and Delana Wardlaw, MD, who practices at Temple Physicians, Inc. at Nicetown, provided perspective to the Philadelphia Inquirer for an article about COVID-19 booster shots. The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) recently authorized Moderna and Johnson & Johnson boosters in certain circumstances, following an earlier recommendation for Pfizer recipients.
- Dr. Reed also spoke with 6ABC about COVID-19 booster shots.
- Amir Emamifar, PharmD, MBA, Vice President and Chief Pharmacy Officer of Temple University Health System, offered insight to Becker’s Hospital Review about the expected approval of Pfizer’s COVID-19 vaccine for children ages 5-11 in the coming weeks.
- Tracheostomy placement in patients with COVID-19 does not decrease length of stay in the hospital or intensive care unit, but the number of deaths was significantly lower for patients with tracheostomy compared with those who did not undergo the procedure, according to a study shared at the annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery earlier in October. The prospective cohort study was presented by Nicole L. Molin, MD, a third-year otolaryngology-head and neck surgery resident at Temple University Hospital. HealthDay highlighted the study.